Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202409867055348Completed
Trial of hyoscine butylbromide (2 arms), sponsored by Self. Primary endpoints: Rate of cervical dilation, Total duration of first stage of labour and 2 more. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202409867055348.